PROJECT SUMMARY Many diseases of aging, including Alzheimer’s disease (AD) and AD related dementia, have been linked with significant metabolic changes that are regulated by diverse molecular classes. Nodes of the aging- and AD-associated metabolic signature include: (i) General proteomic profile as reflecting changes in protein homeostasis and/or an ongoing neurodegenerative event; (ii) Glycosylation of glycoproteins, as reflecting changes in engagement and trafficking along the secretory pathway, as well as “post-delivery” processing cell- surface glycoproteins; and (iii) Biological membrane lipid composition and general bioactive lipid metabolism. Several studies have shown changes in brain metabolism are not uniform throughout AD progression, with parietal, posterior temporal, and anterior occipital lobes most severely affected. Because of this, broad conclusions about the AD brain following analysis that does not include spatial information may be painting an incomplete picture of AD pathogenesis. Due to the complexity of the brain, spatial distribution as well as functional integrations of the above nodes are warranted to understand both aging of the brain and AD pathophysiology. To perform a more comprehensive analysis of region-specific molecular pattern changes in the AD brain, we propose to employ matrix-assisted laser desorption/ionization mass spectrometric imaging (MALDI MSI) technology to examine spatial distribution changes of several molecular classes in animal models of AD as well as postmortem brain tissue of late-onset AD (LOAD) patients. The GENERAL HYPOTHESIS of this research is that alteration in the molecular pattern of various biologically relevant molecular classes can reflect or influence the onset and progression of AD. Aim 1 will map region-specific glycan and glycoprotein expression pattern changes in the whole brain tissue sections of AD mouse models and LOAD patient tissue samples. We will create an atlas of the glycoproteome and illuminating changes in glycosylation that could be key in understanding AD pathogenesis. Aim 2 will map lipidome and unsaturated lipid isomers and changes in metabolic signature in the whole brain tissue sections of AD mouse models and LOAD patient tissue samples. The use of innovative double-bond localization chemistry will expand our current understanding of the AD lipidome, revealing a molecular map of not just lipid classes, but specific lipid isomers within the AD brain. Aim 3 will develop technology- and computationally- driven approaches for biomolecule validation, co-localization, and multidimensional correlation. Our proposed machine learning algorithms will enable simultaneous and region-specific correlation of multiple classes of molecules. Our collaborative team’s orthogonal research foci and interdisciplinary expertise will enable us to generate novel mechanistic and translational data that will inform the research community on the progression of aging and AD. The mechanist...